Table 2.
YLL, YLD and DALYs of 21 skin diseases in Ubonratchathani, overall and by sex.
| Skin diseases | Females | Males | Total DALYs (95% UI) | ||||
|---|---|---|---|---|---|---|---|
| YLL (95% UI) | YLD (95% UI) | DALYs (95% UI) | YLL (95% UI) | YLD (95% UI) | DALYs (95% UI) | ||
| Atopic dermatitis | NA | 156.02 (142.71–169.34) | 156.02 (143.74–168.31) | NA | 99.79 (89.59–110.00) | 99.79 (90.63–108.95) | 255.82 (241.06–270.57) |
| Contact dermatitis | NA | 969.30 (947.81–990.79) | 969.30 (948.37–990.23) | NA | 628.56 (611.06–646.06) | 628.56 (612.10–645.02) | 1597.86 (1571.46–1624.26) |
| Seborrheic dermatitis | NA | 5.04 (4.47–5.61) | 5.04 (4.51–5.57) | NA | 3.46 (2.94–3.98) | 3.46 (3.06–3.86) | 8.50 (7.84–9.15) |
| Psoriasis | NA | 133.58 (122.30–144.87) | 133.58 (123.37–143.80) | NA | 177.41 (165.00–189.82) | 177.41 (164.38–190.44) | 310.99 (293.47–328.52) |
| Cellulitis | 5030.74 (4671.70–5389.78) | 473.57 (462.48–484.67) | 5504.31 (4836.89–6171.73) | 5663.82 (5336.04–5991.60) | 511.81 (500.01–523.61) | 6175.63 (5402.46–6948.80) | 11,679.94 (10,855.02–12,504.86) |
| Impetigo | NA | 16.64 (15.98–17.30) | 16.64 (15.94–17.34) | NA | 17.44 (16.79–18.08) | 17.44 (16.81–18.06) | 34.08 (33.25–34.91) |
| Abscess and other bacterial skin disease | NA | 0.07 (0.03–0.10) | 0.07 (0.02–0.11) | NA | 0.02 (0.00–0.04) | 0.02 (0.00–0.03) | 0.08 (0.04–0.13) |
| Scabies | NA | 2.65 (2.02–3.27) | 2.65 (2.20–3.09) | NA | 2.62 (2.02–3.22) | 2.62 (2.09–3.15) | 5.27 (4.56–5.97) |
| Tinea capitis | NA | 0.95 (0.80–1.10) | 0.95 (0.80–1.11) | NA | 1.28 (1.07–1.50) | 1.28 (1.10–1.47) | 2.24 (2.05–2.43) |
| Other fungal skin disease | NA | 47.96 (46.95–48.97) | 47.96 (46.78–49.14) | NA | 30.32 (29.60–31.05) | 30.32 (29.52–31.13) | 78.28 (76.93–79.63) |
| Wart | NA | 10.62 (9.30–11.94) | 10.62 (9.37–11.87) | NA | 7.73 (6.81–8.65) | 7.73 (6.67–8.79) | 18.35 (16.78–19.93) |
| Molluscum contagiosum | NA | 0.26 (0.05–0.47) | 0.26 (0.08–0.44) | NA | 0.19 (0.04–0.33) | 0.19 (0.01–0.36) | 0.44 (0.17–0.72) |
| Acne vulgaris | NA | 7.81 (5.99–9.64) | 7.81 (6.27–9.36) | NA | 3.60 (2.40–4.79) | 3.60 (2.19–5.00) | 11.41 (8.73–14.08) |
| Alopecia areata | NA | 4.80 (3.77–5.82) | 4.80 (3.78–5.81) | NA | 2.07 (1.50–2.63) | 2.07 (1.65–2.49) | 6.86 (5.93–7.80) |
| Pruritus | NA | 39.95 (38.81–41.10) | 39.95 (38.43–41.47) | NA | 17.73 (16.82–18.65) | 17.73 (16.82–18.64) | 57.68 (56.45–58.92) |
| Urticaria | NA | 886.14 (869.41–902.87) | 886.14 (866.41–905.87) | NA | 558.90 (543.36– 574.44) | 558.9 (542.05–575.75) | 1445.04 (1179.77– 1710.32) |
| Decubitus ulcer | 2141.85 (1964.77–2318.94) | 72.07 (63.37–80.78) | 2213.92 (1862.04– 2565.80) | 2511.87 (2272.39–2751.35) | 80.26 (72.85–87.66) | 2592.13 (2126.77– 3057.48) | 4806.05 (4093.29– 5518.81) |
| Other skin and subcutaneous disease | 1921.82 (1719.76–2123.88) | 53.80 (52.41–55.19) | 1975.62 (1543.82– 2407.42) | 2613.48 (2329.76–2897.20) | 39.21 (38.22–40.20) | 2652.69 (2159.04– 3146.34) | 4628.312 (4004.29– 5252.34) |
| Non-melanoma skin cancersa | 179.62 (127.89–231.35) | 27.90 (22.58–33.22) | 207.52 (85.75–329.30) | 409.89 (310.63–509.15) | 20.49 (16.79–24.20) | 430.38 (214.67–646.10) | 637.91 (438.49–837.32) |
| Melanoma | 120.42 (91.99–148.85) | 102.92 (90.89–114.95) | 223.34 (124.34– 322.34) | 272.28 (219.97–324.59) | 41.50 (34.83–48.17) | 313.78 (156.66–470.90) | 537.12 (362.37–711.87) |
| Total | 9394.45 (8534.88– 10,254.02) | 3013.472 (2978.44–3048.50) | 12407.92 (11416.70–13399.14) | 11,471.34 (10,155.24– 12,787.44) | 2245.416 (2209.76– 2281.07) | 13,716.76 (12,845.59– 14,587.92) | 26,124.68 (24,782.76– 27,466.59) |
95% uncertainly intervals of YLDs, YLLs and DALYs computed using a parametric bootstrap technique.
YLDs years lost due to disability, YLLs years of life lost, DALYs disability adjusted life years, NA not applicable.
aNon-melanoma skin cancers included squamous cell carcinoma and basal cell carcinoma.